Market cap:
$125.60B+$824.30M(+0.66%)Summary
- As of today (April 18, 2025), VRTX market capitalization is $125.60 billion, with a rise of +$824.30 million (+0.66%) during the most recent trading session on April 17, 2025.
- Over the past year, VRTX market cap has increased by +$24.25 billion (+23.93%).
- VRTX market cap is now -6.21% below its all-time high of $133.92 billion.
Performance
VRTX Market cap Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Related metrics
Market cap Formula
Market Cap = Price ✕ Shares Outstanding
VRTX Market cap Trends
PeriodPeriod | Market capMarket cap | PricePrice | Shares outstandingShares outstanding | Enterprise valueEnterprise value |
---|---|---|---|---|
todaytoday | +0.7% | +0.7% | -0.1% | +0.7% |
1 m1 month | -4.8% | -4.8% | - | -4.9% |
3 m3 months | +16.4% | +15.9% | - | +16.8% |
6 m6 months | -2.2% | -1.9% | - | - |
ytdytd | +23.4% | +21.5% | - | +24.1% |
1 y1 year | +23.9% | +24.4% | -0.6% | +32.1% |
5 y5 years | +79.2% | +80.8% | -0.9% | +83.2% |
VRTX Market cap Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | $132B | -4.8% | $121B | +3.5% |
3 m | 3-month | $132B | -4.8% | $108B | +16.4% |
6 m | 6-month | $134B | -6.2% | $101B | +23.8% |
1 y | 1-year | $134B | -6.2% | $101B | +24.5% |
3 y | 3-year | $134B | -6.2% | $60.09B | +109.0% |
5 y | 5-year | $134B | -6.2% | $45.35B | +176.9% |
alltime | all time | $134B | -6.2% | $81.66M | >+9999.0% |
Vertex Pharmaceuticals Incorporated Market cap History
Date | Value |
---|---|
2025 | $125.60B(+23.4%) |
2024 | $101.75B(-3.3%) |
2023 | $105.17B(+41.7%) |
2022 | $74.22B(+32.8%) |
2021 | $55.88B(-9.0%) |
2020 | $61.42B(+8.3%) |
2019 | $56.71B(+34.1%) |
2018 | $42.28B(+11.4%) |
2017 | $37.95B(+107.5%) |
2016 | $18.29B(-41.0%) |
2015 | $30.99B(+7.9%) |
2014 | $28.72B(+65.3%) |
2013 | $17.37B(+90.8%) |
2012 | $9.10B(+31.0%) |
2011 | $6.95B(-2.5%) |
2010 | $7.13B(-16.8%) |
2009 | $8.57B(+87.4%) |
Date | Value |
---|---|
2008 | $4.57B(+48.1%) |
2007 | $3.09B(-34.6%) |
2006 | $4.72B(+57.7%) |
2005 | $2.99B(+250.6%) |
2004 | $853.68M(+5.7%) |
2003 | $807.56M(-33.3%) |
2002 | $1.21B(-34.4%) |
2001 | $1.85B(-56.7%) |
2000 | $4.26B(+374.1%) |
1999 | $898.98M(+19.2%) |
1998 | $754.43M(-9.3%) |
1997 | $832.13M(-2.0%) |
1996 | $849.15M(+85.2%) |
1995 | $458.42M(+77.8%) |
1994 | $257.83M(+14.5%) |
1993 | $225.22M(+89.7%) |
1992 | $118.70M(-32.0%) |
1991 | $174.61M |
FAQ
- What is Vertex Pharmaceuticals Incorporated market capitalization?
- What is the all time high market cap for Vertex Pharmaceuticals Incorporated?
- What is VRTX market capitalization year-to-date change?
- What is Vertex Pharmaceuticals Incorporated market cap year-on-year change?
What is Vertex Pharmaceuticals Incorporated market capitalization?
The current market cap of VRTX is $125.60B
What is the all time high market cap for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high market capitalization is $133.92B
What is VRTX market capitalization year-to-date change?
Vertex Pharmaceuticals Incorporated market capitalization has changed by +$23.85B (+23.44%) since the beginning of the year
What is Vertex Pharmaceuticals Incorporated market cap year-on-year change?
Over the past year, VRTX market capitalization has changed by +$24.25B (+23.93%)